The Disease of the Italian Poet Giacomo Leopardi (1798-1837): A Case of Juvenile Ankylosing Spondylitis in the 19th Century?

The chemistry of a fossilised elephant tooth: Domenico Morichini and the discovery of dental fluoride

On the occasion of the 250th anniversary of the birth of the Italian physician, Domenico Morichini (1773-1836), this study aims to commemorate this illustrious figure, who made a great contribution to the history of dentistry through his discovery of the presence of fluoride in dental enamel. Starting from a chemical analysis of the components of the enamel and osseous part of a fossilised elephant tooth discovered in Rome in 1802, Morichini demonstrated the presence of high amounts of fluoride, not only in these remains, but also in samples of human teeth. The Italian doctor, a Professor of Chemistry at the Sapienza University of Rome, also affirmed the importance of his discovery from a clinical perspective, as it enabled a better understanding of the chemical composition of enamel, changes in which he saw as the cause of most dental diseases. Morichini was a talented clinician and scientist, who also made contributions in other medical-scientific fields, as one of the first to suggest the electromagnetic nature of solar radiation based on experiments that were replicated internationally.

Association of Congestive Heart Failure and Death with Ankylosing Spondylitis : A Nationwide Longitudinal Cohort Study in Korea

Objective

We attempted to discover that Ankylosing spondylitis (AS) has a comprehensive relationship with congestive heart failure and death.

Methods

We used a nationwide database managed by the Korean National Health Insurance Service from 2010 to 2014. Twelve thousand nine hundred eighty-eight patients with a diagnosis of AS and 64940 age- and sex- stratified matching subjects without AS were enrolled in the AS and control groups. Incidence probabilities of 6 years congestive heart failure and death in each group were calculated. The Cox proportional hazard regression analysis was used to estimate the hazard ratio. We divided the AS and control groups into subgroups according to sex, age, income, and comorbidities.

Results

During the follow-up period, 102 patients (0.79%) in the AS group and 201 patients (0.32%) in the control group developed congestive heart failure (p<0.0001). In addition, 211 (1.62%) subjects in the AS group died during the follow-up period compared to 639 (0.98%) subjects in the control group (p<0.0001). The adjusted hazard ratio of congestive heart failure and death in the AS group was 2.28 (95% confidence interval [CI], 1.80–2.89) and 1.66 (95% CI, 1.42–1.95), respectively. The hazard ratios of congestive heart failure and death were significantly increased in all of the subgroups.

Conclusion

The incidence rates of congestive heart failure and death were increased in AS patients.